Advances in Pathogenesis and Treatment of Colonic Diverticular Disease

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".

Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 173

Special Issue Editor


E-Mail Website
Guest Editor
Em. Head of the Clinic for Internal Medicine and Gastroenterology, Protestant Hospital Kalk, University of Cologne, Cologne, Germany
Interests: inflammatory bowel disease (IBD); Crohn´s disease; ulcerative colitis; controlled trials in IBD; observations in rare manifestations of IBD; pharmacological studies; studies on pathogenesis of IBD
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Diverticular disease of the colon (DDC) is a paradox. Its prevalence and the burden for patients and healthcare systems are steadily increasing, but scientific efforts need more support and intensified collaborative strategies. Traditionally, lifestyle factors are thought to be the pathogenetic basis for the development of diverticulosis, while recent research disputes this concept. New insights into the genetic, molecular, and pathological background of the disease have emerged lately, but a conclusive pathogenetic model is still missing. Recommendations for treatments are changing accordingly. Antibiotics as first-line therapy in diverticulitis were nearly unanimously accepted, but results from recent trials question this concept. More insight into the pathogenesis, new targets of treatment, and more interdisciplinary discussion of controversial questions is urgently needed. The focus of Biomedicines is directed towards genetic mechanisms and molecular and pathological characteristics and their translation to medicine. Thus, a Special Issue of Biomedicines is very well adapted to foster the kind of information needed.

Dr. Wolfgang Kruis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • colonic diverticular disease
  • diverticulitis
  • pathogenesis
  • diagnosis
  • treatment

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop